Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

By sjmartinez • November 19, 2024

Abdel Jawad M, Spertus JA, Ikeaba U, Greene SJ, Fonarow GC, Chiswell K, Chan PS. Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction. JAMA Cardiol. 2024 Nov 18:e244489. doi: 10.1001/jamacardio.2024.4489. Epub ahead of print. PMID: 39556474; PMCID: PMC11574726.

Tags: Cardiology/Epi, Publications

Author Correction: Viscoelastic synthetic antigen-presenting cells for augmenting the potency of cancer therapies

Liu Z, Li YR, Yang Y, Zhu Y, Yuan W, Hoffman T, Wu Y, Zhu E, Zarubova J, Shen J, Nan H, Yeh KW, Hasani-Sadrabadi[...]

The Impact of Intravascular Ultrasound Use on 1-Year Outcomes After Infrapopliteal Endovascular Intervention

Snyder DJ, Zilinyi RS, Kido T, Saleem D, Dreyfus I, Bruce S, Wadden E, Girvin Z, Finn MT, Kirtane AJ, Maehara A, Sethi SS, Parikh[...]

Visit-to-Visit Variability in Lipid Levels and Risk of Incident Heart Failure in Adults With Type 2 Diabetes

Kaze AD, Ndumele CE, Martin SS, Santhanam P, Yeneneh BT, Farouk M, Tung R, Fonarow GC, Echouffo-Tcheugui JB. Visit-to-Visit Variability in Lipid Levels and Risk[...]